SCTX

12.1608.02%
BA

Behzad Aghazadeh

Independent Director

Mr. Behzad Aghazadeh, Ph.D. is an Independent Director of Scribe Therapeutics Inc. from March 2021. He is Managing Partner, Avoro Ventures and Avoro Capital Advisors He served as the Chairman of Immunomedics, a clinical-stage biopharmaceutical company. He received his Master’s degree in Physics from the Ludwig-Maximilians-University (Munich, Germany) and a PhD from Cornell University in Biochemistry & Biophysics.

Positions